openPR Logo
Press release

Insulin Pump Market Size, Growth, Opportunities 2024-2032 | Medtronic, Tandem Diabetes Care, Inc., Ypsomed AG, Insulet Corporation, Hoffmann-La Roche Ltd

10-04-2024 08:38 AM CET | Health & Medicine

Press release from: Fortune Business Insights

Insulin Pump Market

Insulin Pump Market

The insulin pump market has experienced substantial growth driven by the increasing prevalence of diabetes, particularly type 1 diabetes, and the demand for more efficient and effective diabetes management solutions. Insulin pumps are designed to deliver continuous subcutaneous insulin, providing a more stable blood glucose level compared to traditional insulin injections. The market is characterized by a variety of innovative products, with advancements in technology leading to the development of smart insulin pumps that integrate with continuous glucose monitoring systems. These devices enhance user experience by allowing patients to monitor their glucose levels and adjust insulin delivery in real-time.

๐——๐—ถ๐˜€๐—ฐ๐—ผ๐˜ƒ๐—ฒ๐—ฟ ๐—ช๐—ต๐—ฎ๐˜ ๐—ฌ๐—ผ๐˜‚'๐—ฟ๐—ฒ ๐— ๐—ถ๐˜€๐˜€๐—ถ๐—ป๐—ด: ๐—š๐—ฒ๐˜ ๐—ฎ ๐—™๐—ฟ๐—ฒ๐—ฒ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ (๐—ฃ๐——๐—™) ๐—ฆ๐—ฎ๐—บ๐—ฝ๐—น๐—ฒ : https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/insulin-pump-market-102735

๐—ž๐—ฒ๐˜† ๐—œ๐—ป๐—ฑ๐˜‚๐˜€๐˜๐—ฟ๐˜† ๐——๐—ฒ๐˜ƒ๐—ฒ๐—น๐—ผ๐—ฝ๐—บ๐—ฒ๐—ป๐˜ :

๐—๐—ฎ๐—ป๐˜‚๐—ฎ๐—ฟ๐˜† ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฐ: PharmaSens, a Switzerland-based medical device company, submitted an application to seek an approval from the U.S. FDA for its new insulin pump. The company received ISO 13485 certification in November 2023.

๐—ง๐—ผ๐—ฝ ๐—ฐ๐—ผ๐—บ๐—ฝ๐—ฎ๐—ป๐—ถ๐—ฒ๐˜€ ๐—ถ๐—ป ๐˜๐—ต๐—ฒ ๐—œ๐—ป๐˜€๐˜‚๐—น๐—ถ๐—ป ๐—ฃ๐˜‚๐—บ๐—ฝ ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ :

โ€ข Medtronic (Ireland)
โ€ข Tandem Diabetes Care, Inc. (US)
โ€ข Ypsomed AG (Switzerland)
โ€ข Insulet Corporation (US)
โ€ข CeQur Simplicity (Switzerland)
โ€ข Microtec Medical Ltd (U.K.)
โ€ข ViCentra B.V. (Netherlands)
โ€ข SOOIL Developments Co., Ltd (Korea)
โ€ข EOFLOW CO., LTD. (Korea)

๐—ฆ๐—ฒ๐—ด๐—บ๐—ฒ๐—ป๐˜๐˜€ :

The insulin pump market is segmented based on several criteria, including product type, technology, end-user, and distribution channel. Product types primarily include traditional insulin pumps, smart insulin pumps, and patch pumps, each catering to different patient needs and preferences. In terms of technology, the market is divided into continuous glucose monitoring (CGM) integrated pumps and non-CGM integrated pumps, with CGM integration being a key driver for adoption due to its enhanced monitoring capabilities. The end-user segment encompasses hospitals, clinics, and home care settings, with a growing preference for home care solutions due to their convenience and flexibility. Distribution channels further categorize the market into online sales, retail pharmacies, and hospital pharmacies, reflecting the changing purchasing behaviors of consumers. Additionally, geographical segmentation highlights the differences in market dynamics across regions such as North America, Europe, Asia-Pacific, and the rest of the world, each influenced by varying healthcare policies, diabetes prevalence, and technological adoption rates

๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—–๐—ผ๐˜ƒ๐—ฒ๐—ฟ๐—ฎ๐—ด๐—ฒ :

The report has studied the market in depth and underlined several crucial aspects and leading market participants. It provides important insights into the recent market trends and key industry developments. In addition to the factors mentioned above, the report covers many other factors that have helped the market grow.

๐—™๐—ผ๐—ฟ ๐—™๐˜‚๐—น๐—น ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—–๐—ผ๐˜ƒ๐—ฒ๐—ฟ๐—ฎ๐—ด๐—ฒ ๐—ฉ๐—ถ๐˜€๐—ถ๐˜ : https://www.fortunebusinessinsights.com/insulin-pump-market-102735

๐——๐—ฟ๐—ถ๐˜ƒ๐—ฒ๐—ฟ๐˜€ ๐—ฎ๐—ป๐—ฑ ๐—ฅ๐—ฒ๐˜€๐˜๐—ฟ๐—ฎ๐—ถ๐—ป๐˜๐˜€ :

The insulin pump market is driven by several key factors, including the increasing prevalence of diabetes, advancements in technology, and growing awareness of the benefits of insulin pumps for managing blood glucose levels. The demand for more effective diabetes management solutions, particularly among type 1 diabetes patients, propels the adoption of insulin pumps, especially those with integrated continuous glucose monitoring systems that provide real-time data and automated insulin delivery. However, the market also faces certain restraints, such as the high costs associated with insulin pumps and related supplies, which can limit access for some patients. Additionally, challenges related to device usability, potential technical issues, and the need for patient education on proper usage may hinder widespread adoption. Furthermore, varying reimbursement policies across regions can affect market growth, creating disparities in access to insulin pump therapy.

๐—ฅ๐—ฒ๐—ด๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—œ๐—ป๐˜€๐—ถ๐—ด๐—ต๐˜๐˜€ :

The insulin pump market exhibits diverse regional insights, with North America leading in market share due to a high prevalence of diabetes, advanced healthcare infrastructure, and widespread acceptance of technology in diabetes management. The presence of major manufacturers and favorable reimbursement policies further drive growth in this region. Europe also shows significant adoption, influenced by increasing health awareness and advancements in diabetes management technologies, although regulatory complexities can vary between countries. The Asia-Pacific region is emerging as a promising market, fueled by rising diabetes cases, improving healthcare access, and greater emphasis on personalized medicine. Countries like China and India are experiencing rapid growth as they implement initiatives to enhance diabetes care. Latin America and the Middle East and Africa represent smaller markets, with growth potential linked to increasing healthcare investments and rising awareness of diabetes management solutions. However, challenges such as economic disparities and limited access to advanced healthcare technologies can hinder market penetration in these regions.

๐—–๐—ผ๐—บ๐—ฝ๐—ฒ๐˜๐—ถ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—Ÿ๐—ฎ๐—ป๐—ฑ๐˜€๐—ฐ๐—ฎ๐—ฝ๐—ฒ :

The competitive landscape of the insulin pump market is marked by the presence of several key players striving to innovate and capture market share through advanced technologies and product differentiation. Leading companies such as Medtronic, Tandem Diabetes Care, and Insulet Corporation dominate the market by offering a range of insulin delivery systems, including traditional pumps, patch pumps, and smart pumps integrated with continuous glucose monitoring. These firms invest significantly in research and development to enhance product features, improve user experience, and ensure regulatory compliance. Additionally, emerging players are entering the market with novel solutions, focusing on niche segments or developing more affordable devices to broaden accessibility. Strategic partnerships and collaborations with healthcare providers and technology firms further enrich the competitive dynamics, enabling companies to leverage complementary expertise and expand their reach. The landscape is characterized by ongoing innovation, with a strong emphasis on enhancing patient outcomes and simplifying diabetes management, making it a dynamic and rapidly evolving sector.

๐—–๐˜‚๐˜€๐˜๐—ผ๐—บ๐—ถ๐˜‡๐—ฒ ๐˜๐—ต๐—ถ๐˜€ ๐—ฟ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—ฎ๐—ฐ๐—ฐ๐—ผ๐—ฟ๐—ฑ๐—ถ๐—ป๐—ด ๐˜๐—ผ ๐˜†๐—ผ๐˜‚๐—ฟ ๐—ฐ๐—ผ๐—ป๐˜ƒ๐—ฒ๐—ป๐—ถ๐—ฒ๐—ป๐—ฐ๐—ฒ : https://www.fortunebusinessinsights.com/enquiry/ask-for-customization/insulin-pump-market-102735

Contact Us:
Fortune Business Insightsโ„ข Pvt. Ltd.
9th Floor, Icon Tower,
Baner, Pune-411045,
Maharashtra, India.
Phone:
U.S.: US +1 833 909 2966 (Toll Free)
UK +44 808 502 0280 (Toll Free)
APAC +91 744 740 1245
Email: sales@fortunebusinessinsights.com

About Us:
Fortune Business Insightsโ„ข offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Insulin Pump Market Size, Growth, Opportunities 2024-2032 | Medtronic, Tandem Diabetes Care, Inc., Ypsomed AG, Insulet Corporation, Hoffmann-La Roche Ltd here

News-ID: 3677719 • Views: โ€ฆ

More Releases from Fortune Business Insights

Bioplastics Market Poised for Remarkable Growth, set to Reach USD 56.99 billion by 2032 with a CAGR of 29.0%.
Bioplastics Market Poised for Remarkable Growth, set to Reach USD 56.99 billion โ€ฆ
The global bioplastics market was valued at USD 7.49 billion in 2023 and is expected to decline slightly to USD 7.41 billion in 2024 before surging to USD 56.99 billion by 2032, growing at a CAGR of 29.0% during the forecast period. Europe dominated the bioplastics market with a market share of 48.6% in 2023. Bioplastics refer to materials that have been made from renewable sources and play an important roleโ€ฆ
Nutraceutical Packaging Market Size, Share & Industry Analysis | Key Trends & Developments, 2032
Nutraceutical Packaging Market Size, Share & Industry Analysis | Key Trends & De โ€ฆ
The global nutraceutical packaging market size was valued at USD 3.90 billion in 2023 and is projected to be worth USD 4.08 billion in 2024 and reach USD 6.24 billion by 2032, exhibiting a CAGR of 5.45% during the forecast period. The rising emphasis on eco-friendly packaging is set to drive the product demand, propelling industry expansion. The use of nutraceutical packaging helps enhance resistance to oxidation and offers protectionโ€ฆ
Activated Carbon Market Poised for Remarkable Growth, set to Reach USD 10.04 billion by 2032 with a CAGR of 8.7%.
Activated Carbon Market Poised for Remarkable Growth, set to Reach USD 10.04 bil โ€ฆ
The global activated carbon market size was valued at USD 5.70 billion in 2024. The market is projected to grow from USD 5.62 billion in 2025 to USD 10.04 billion in 2032, recording a CAGR of 8.7% during 2025-2032. Activated carbon, also called activated charcoal, is a form of carbon that is majorly used in air purification and gas cleaning applications as they have a high absorption capacity and porosity. Theโ€ฆ
Organic Foods Market Poised for Remarkable Growth, set to Reach USD 529.64 billion by 2032 with a CAGR of 12.99%.
Organic Foods Market Poised for Remarkable Growth, set to Reach USD 529.64 billi โ€ฆ
The global organic foods market was valued at USD 177.08 billion in 2023 and is anticipated to reach USD 199.35 billion in 2024, eventually growing to USD 529.64 billion by 2032. This growth reflects a compound annual growth rate (CAGR) of 12.99% during the forecast period. In 2023, Europe led the global organic foods market, accounting for 44.17% of the market share. The organic food market in the United States isโ€ฆ

All 5 Releases


More Releases for Insulin

Insulin Patch Pumps Market Report 2018: Segmentation by Insulin Type (Bolus Insu โ€ฆ
Global Insulin Patch Pumps market research report provides company profile for Roche Holding AG, Cellnovo Group SA, Spring Health Solution Ltd., Debiotech, CeQur SA, Valeritas, Becton Dickenson & Company, Insulet Corporation, Johnson & Johnson, Medtrum Technologies Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue,โ€ฆ
Bluetooth connected smart insulin pens represent the future of insulin delivery โ€ฆ
Increasing pool of diabetic patients witnessed across the globe has prompted leading manufacturers of medical devices towards development of ground-breaking products. Smart insulin pens are among such devices that have revolutionised the global market for diabetic injection pens. A recent study published by Future Market Insights projects that the global smart insulin pens market, which is currently valued at US$ 0.86 Mn, will expand vigorously at 17.9% CAGR through theโ€ฆ
Insulin pump Market Explore Future Growth 2018-2026 by Global Type-Traditional i โ€ฆ
Insulin pump is a portable device attached to the body that continuously delivers preset amounts of short or rapid acting insulin in the body to control diabetes. Insulin therapy is required in type 1 diabetes and sometime in type 2 diabetes. It serves as an effective alternative to insulin injections. Furthermore, insulin pump delivers the insulin according to the need of body as basal rate, where small amount of insulinโ€ฆ
Insulin Drug and Delivery Technologies Market Report 2018: Segmentation by Produ โ€ฆ
Global Insulin Drug and Delivery Technologies market research report provides company profile for Julphar, Ypsomed, Becton, Dickinson and Company, Sanofi, Eli Lilly and Company, Biocon and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc.โ€ฆ
09-06-2017 | Health & Medicine
MRRSE
Smart Insulin Pens Market: Bluetooth Connected Smart Insulin Pens Allow Effectiv โ€ฆ
By connectivity, the Bluetooth connected smart insulin pen segment is expected to account for a value share of US$ 0.276 Mn in 2017. The segment is expected to reach a little more than US$ 2 Mn by 2027 end, registering the highest CAGR of 23.2% over the forecast period. Bluetooth connected smart insulin pens represent the future of insulin delivery devices. Such devices have an inbuilt Bluetooth connectivity feature allowingโ€ฆ
Biosimilar Insulin Market Biosimilar Insulin Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Prologue to Insulin Biosimilars 1.1 Outline Towards Insulin 1.2 Trail of Insulin Evolution and Development Rationale Design of Insulin Molecule 2.1 Structure of Insulin Polypeptide 2.2 Biosynthesis of Insulin 2.3 Secretion of Insulin Mechanism of Insulin in Diabetics 3.1 Glucose Metabolism of Insulin 3.2 Impact of Insulin Dysregulation in Diabetes 1 3.3 Impactโ€ฆ